News & Insights

China's Innovent and Pfizer have signed a $10.5 billion collaboration agreement to conduct clinical trials across 12 cancer drug programs. The two parties will focus on oncology R&D, aiming to accumulate more clinical research data; specific efficacy remains to be validated by subsequent trials.

专家指出，我国核医学装备自主创新已实现从跟跑到并跑、部分领跑，国产设备核心软硬件全国产化并通过多中心临床验证。其本土化运维、智能操作与核药配送体系，正推动优质核医学资源下沉县域，打通精准医疗最后一公里。

Large top-tier Chinese hospitals are rapidly establishing international medical departments, obtaining JCI accreditation, and leading in cutting-edge fields such as CAR-T and proton therapy. International medical brands are entering the market, and Sino-foreign partnerships are growing, offering more diversified high-end medical choices for both Chinese and international patients.

The Ministry of Commerce and five other departments jointly launched a pilot program for the integrated development of TCM service consumption and service trade, with 18 regions including Chongqing and Chengdu selected for the pilot list.

From organizing medical records and remote consultations to entry treatment plans, SINCURE outlines the most critical preparation points for premium clients before initiating cross-border medical services.